Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing ABZYMO Biosciences
Beijing, Beijing, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Beijing ABZYMO Biosciences provides commercial raw materials (proteins, antibodies, enzymes) for in vitro diagnostics and is advancing recombinant vaccine candidates (notably shingles, HPV) with at least one program in Phase 3 clinical trials[5].
- Therapeutic areas
- Infectious Diseases
- Modalities
- Recombinant proteinAntibodyEnzymeProtein
- Industry
- Biotech
02
Partnerships
Collaborations on clinical trials (Chinese hospitals, CDC; specifics not identified)
Beyond the preview
Go deeper on Beijing ABZYMO Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Beijing ABZYMO Biosciences.